Losing weight is a frustrating endeavor that leaves men and women with troubling problem areas around their waist and thighs. Unfortunately, there are all sorts of companies that seek to take advantage of people who don't know how to lose stomach fat by offering potentially dangerous supplements and fad products.
We all agree as do most experts, that there is no real secret to losing fatty abdominal tissue other than eating a low-calorie diet and exercising consistently. That said, a pair of recent studies suggest dieters may be able to improve their efforts by changing their intestinal flora.
Changing Intestinal microflora:
Recently, a study conducted by researchers from Snow Brand Milk Products reinforced previous findings suggesting that probiotics can help dieters lose stomach fat. Previously, researchers at Kyushu University proved that fermented milk changed the composition of intestinal microflora in mice to speed their metabolisms. To see if this applied to humans, this latest study gave several subjects a fermented milk product containing the Probiotic Lactobacillus. After twelve weeks, the researchers noted a 4.6% drop in abdominal fat, along with a 3.3% drop in subcutaneous fat. Read more
A study was done to compare gastrointestinal permeability and fecal calprotectin concentration in children ages 7 to 10 years that have functional abdominal pain and irritable bowel syndrome (IBS) vs Controls and ascertain potential relationships with stooling and pain symptoms.
In the study, GI permeability (Leaky Gut) and fecal calprotectin concentration were measured. Children kept a two-week diary of pain episodes and stooling pattern. The children with IBS had evidence of increased GI permeability and low grade GI inflammation with the latter relating to the degree to which pain interferes with activities. Read more
From Medscape Medical News
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) may decrease the risk for developing squamous cell carcinoma (SCC) or malignant melanoma (MM), according to a new population-based, case-control study published online on May 29.
Use of NSAIDs overall (>2 prescriptions) was associated with a decreased risk for SCC (incidence rate ratio [IRR], 0.85; 95% confidence interval [CI], 0.76 - 0.94) and MM (IRR, 0.87; 95% CI, 0.80 - 0.95) compared with nonuse (=2 prescriptions). This was especially true for long-term use (=7 years) and high-intensity use (>25% prescription coverage during the total duration of use). Although NSAID use was not associated with a reduced risk for basal cell carcinoma (BCC) overall (IRR, 0.97; 95% CI, 0.93 - 1.01), a reduced risk for BCC at sites other than the head was noted with long-term use (IRR, 0.85; 95% CI, 0.76 - 0.95) and high-intensity use (IRR, 0.79; 95% CI, 0.69 - 0.91).
"The effect [of NSAIDs] increased with greater duration and intensity of use, which may reflect a cumulative biologic effect (ie, a dose-response effect) exerted in the initiation of carcinogenesis," wrote Sigrun Alba Johannesdottir, BSc, from the Department of Clinical Epidemiology, Aarhus University Hospital, Denmark, and colleagues. Read more
GET 20% OFF on ALL Nordic Naturals Products: Use Coupon Code CPN0801
Buy One GanoExcel Coffee box and GET ONE FREE: Use Coupon Code CPN0802